Featured Drug Formulation Technology Platforms

Sustained and Controlled Release Technology Platform

Sustained and controlled release technology allows for the gradual release of a drug over an extended period. By reducing dosing frequency, it enhances patient compliance, minimizes side effects, and maintains consistent drug plasma levels.

Solubility Enhancement Technology Platform

Poorly soluble drugs often suffer from low bioavailability, which can hinder their therapeutic efficacy. Solubility enhancement technology tackles this challenge by using techniques such as solid dispersion, micronization, and nanotechnology.

Liquid Formulation Technology Platform

Liquid formulation technology is essential for administering drugs to populations that may have difficulty swallowing pills, such as pediatric and geriatric patients. This platform facilitates the development of solutions, suspensions, emulsions, and other liquid dosage forms.

Softgel Technology Platform

Softgel technology offers numerous advantages for drug delivery, including improved bioavailability, superior patient compliance, and versatile applications. It is particularly beneficial for delivering lipid-based formulations and poorly soluble drugs.

Orally Fast Dissolving Technology Platform

Orally fast dissolving technology caters to the growing demand for convenient and patient-friendly dosage forms. This technology enables tablets to dissolve rapidly in the mouth without the need for water, offering a significant advantage for patients with swallowing difficulties.

Lyophilized Formulation Technology Platform

Lyophilized formulations are created through a process of freezing the drug solution and then removing the ice by sublimation under vacuum conditions. The platform is essential for developing stable, long-lasting drugs that require stringent storage conditions.

Taste Masking Technology Platform

Taste masking technology effectively masks the unpleasant taste of APIs, which is critical for enhancing the palatability of orally administered drugs, which directly impacts patient compliance, especially for pediatric and geriatric populations.